Rentokil Initial PLC

Rentokil Initial PLC (RTO) News & Events

$23.530

+0.061 (+0.26%)At close

RTO News

RTO Events

7/30 12:30

Rentokil Initial Shares Down 18.3% to $24.05

Rentokil Initial is down -18.3%, or -$5.38 to $24.05.

7/30 10:30

Rentokil Initial Shares Down 17.9% to $24.15

Rentokil Initial is down -17.9%, or -$5.28 to $24.15.

7/6 20:00

Large-Cap Growth Stocks Shine, Crinetics Pharmaceuticals Up 100%

Risk-on sentiment resurfaced following the long holiday weekend as large-cap growth areas of the market handily outperformed SMIDs and value.  Comms Services, Tech, and Financials were the best performing sectors on the S&P 500, while the defensively oriented  Healthcare, Staples, and Utilities lagged.  Computer Hardware had an especially strong day - Arista Networkswas up 8.3%, Western Digitalgained 7.1% and Seagaterallied 5.9%.   A softer than expected non-farm payrolls dented expectations of tightening, but that narrative was also defied by the price action in the Treasury market as yields on the short-end of the curve remained elevated while longer-dated maturities remain elevated.   Service ISM data also came in softer somewhat, though the indicator remained in expansion - as it has for the past two years.In the evening hours, equity index futures are mixed - S&P e-minis are flat while Nasdaq 100 is off by 0.2%.  In commodities, WTI Crude Oil is marginally higher but still below $70 per barrel while precious and base metals are up by about 0.2%.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER -Crinetics Pharmaceuticalsup 100% after being acquired by Vertex Pharmaceuticals, which is down 2.3%Aligos Therapeuticsup 14.9% after receiving a $25M upfront payment for pevifoscorvir sodium license dealFirst Solarup 2.1% after being upgraded to buy at Deutsche BankRentokil Initial plcup 1.9% after being upgraded to Buy at Goldman SachsAbbVieup 0.3% after Q2 pre-announcementLOWER -Riviandown 8.8% after 75M share equity offering.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started